GlassScriptPhysician profile
Mohammad Rasekhi
NPI 1043361546
$783.49
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $93.02 · 2021: $189 · 2022: $119 · 2023: $27.35 · 2024: $68.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $142.88 | 2021 | |
| Amgen INC. | $108.38 | 2019-2020 | |
| Horizon Therapeutics Plc | $93.03 | 2019-2021 | |
| Abbott Laboratories | $68.31 | 2019-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $53.18 | 2022-2023 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $45.48 | 2022-2024 | Wegovy |
| Allergan, INC. | $37.02 | 2019-2020 | |
| Phadia US INC. | $35.51 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.29 | 2022 | |
| Merck Sharp & Dohme LLC | $34.00 | 2019 | |
| Glaxosmithkline, LLC. | $25.60 | 2019 | |
| Mannkind Corporation | $24.72 | 2019 | |
| Daiichi Sankyo INC. | $23.63 | 2019 | |
| Cranial Technologies, INC | $21.69 | 2022 | |
| Radius Health, INC. | $20.51 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Rasekhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.